To main content (press Enter)

1st in market capitalisation in EU

24% of the EU biotech market value (BE)

Gross Value Added of 4,1 billion euros in 2019

4x higher than surrounding EU countries (WAL)

Continuous employment growth rate the last 15 year

(between 5-10% yearly) (WAL)

More than 350 biotech companies (WAL)

A unique connected ecosystem

AWEX ecosystem

Doing business in Wallonia is a matter of working together. Become part of a tight-knit collaborative ecosystem of clusters, incubators, universities, research centers, hospitals, federal and regional government organizations, and public and private investors.

Biotech companies enjoy a prominent place in Wallonia. Indeed, products from the chemical and the biomanufacturing industries are by far our leading export sector, with more than 30% of the Walloon total. At a European level Wallonia is considered as key player in life sciences. We should rightfully be proud of this, but we mustn't rest on our laurels. This is why the Wallonia Export & Investment Agency will continue to attach specific importance to the growth potential of the biomanufacturing sector, which is essential to remain in pole position among the regions at the vanguard of the biotech sector. Pascale Delcomminette (CEO Wallonia Export & Investment Agency)

Did you know?

Wallonia and Belgium as a whole have a long and successful history in biotech discoveries. The Belgian biotech story started in the university laboratories, but since then many successful biotech and biomanufacturing startups and multinationals, like GSK and Kaneka Eurogentec, have found common ground in Wallonia. Some of the main highlights through the years:

  1. 1928

    UCB was created by Emmanuel Janssen, a company initially focused on industrial chemicals. In the early 1950s, UCB set up a research centre where new medicines were developed. Today UCB is a Belgian multinational biopharmaceutical company that continues to invest in Belgium. It has recently announced 2 big investments in biomanufacturing in Belgium.

  2. 1956

    RIT – now GSK – produces the world’s first polio vaccine in Belgium. Today, GSK Belgium is the world’s largest producer of vaccines.

  3. 1978

    Walloon researcher Joseph Martial clones the gene for the human growth hormone.

  4. 1985

    Walloon researcher Joseph Martial creates Eurogentec, one of the first spin-offs according to the American model. Today Kaneka Eurogentec is a leading international CDMO offering plasmide DNA and mRNA vaccine production.

  1. 1999

    Walloon professor in Gynaecology, Jean-Michel Foidart, co-founded Mithra as spin-off of the university of Liège. Today Mithra is an international CDMO and pursuing its innovation and development in the field of Women’s Health.

  2. 1999

    The Brussels South Charleroi BioPark was created through a unique combination of political, scientific and social factors resulting in a supportive ecosystem for drug discovery and development across the spectrum of life sciences companies from innovative start-ups through to global players.

  3. 2006

    Walloon professor Cédric Blanpain started his laboratory, the Blanpain Lab, laboratory of stem cells and cancer, at the ULB (Université Libre de Bruxelles). He was one of the first researchers in the world to use cell lineage tracing in cancer research and he showed for the first time the existence of cancer stem cells in solid tumors in vivo. He is an international recognised professor and has received several prices honouring his stem cell research.

  4. 2013

    Entrepreneurs Hughes Bultot and José Castillo create Univercells, specialised in cutting-edge bioprocessing technologies. Today Univercells consists of 5 businesses leveraging core strengths in scaling, production and bioprocessing to revolutionize the availability of biologics around the world.

  5. 2020

    Many Walloon companies play an important role in the development and production of COVID-19 vaccines.

Frederik druck
Thanks to their knowledge, their collaboration in open innovation with both academic and private research actors, the strong support of the Walloon Region, and also thanks to a growing ecosystem, Belgian biotech companies now manage to achieve revolutionary developments and results in about twenty years. Frédéric Druck, Secretary General of

End-to-end services for your biotech needs

From R&D to bioproduction and logistics: Wallonia offers access to a range of services and facilities that support your biotech or biomanufacturing ambitions. Here are just some of the potential partners that can help your biotech business boom:

Home to some of the world’s top universities

Home to world-renowned universities with excellent track records in life sciences like ULB, UMons, UNamur, UCLouvain and ULiège, your biotech company can reap the benefits of close collaboration with some of the world’s best researchers.

Want to become a part of
Wallonia’s buzzing biotech scene?